Back

Statin therapy and synergistic effect of ezetimibe for the prevention of stroke with atrial fibrillation populations: nationwide cohort study

14 April 2026 (09:30 - 10:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation and the brain Mechanisms for Stroke EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Changhyeon Kim

Chonnam National University Hospital, Gwangju (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Phenotypic clustering of patients with atrial fibrillation at high risk of bleeding and stroke: insights from three global registries
Doctor A. Askarinejad (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Importance of atrial cardiomyopathy in patients with embolic stroke of unknown cause and its prognostic significance
Professor M. Gotzmann (Bochum, DE)
Abstract Slides Video
Presentation thumbnail
Prolonged ECG monitoring after transient ischaemic attack for atrial fibrillation detection: feasibility of using meta-machine learning algorithm
Doctor J. Tan (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Cognitive function and working memory assessment using the REMEDES system in patients with atrial fibrillation
Doctor K. Triantafyllou (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Quality of life after atrial fibrillation ablation: a comparison of pulsed-field versus radiofrequency energy
Doctor C. Isenegger (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation and the brain

The Event

Event poster

EHRA 2026

14 April 2026 09:30 CET
You may be interested in
thumbnail
Congress Presentation
Impact of statin and ezetimibe for the prevention of stroke in patients with atrial fibrillation
thumbnail
Congress Presentation
The long-term usage of statin prevents adverse events in patients with atrial fibrillation
thumbnail
Congress Presentation
Combination of moderate-intensity statins and ezetimibe versus high-intensity statins alone for primary prevention of cardiovascular events

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources